A Bard Eclipse IVC filter lawsuit was recently filed by a woman alleging she suffered severe adverse effects and complications after being implanted with the Bard Eclipse IVC filter device.

Plaintiff Mary V. files the Bard Eclipse IVC filter lawsuit in Arizona federal court, joining a growing multidistrict litigation (MDL) against the C.R. Bard company. The lawsuit was filed on July 17, 2018, demanding a trial by jury.

According to the Bard Eclipse IVC filter lawsuit, Mary is a resident of the State of Colorado. She says she was implanted with the Eclipse Vena Cava Filter device on Dec. 18, 2012. However, she alleges she soon suffered severe adverse effects and complications including device perforation.

The Bard Eclipse IVC filter lawsuit was filed on multiple counts including manufacturing defect, failure to warn, design defect, negligence, negligent misrepresentation, negligence per se, breach of express warranty, breach of implied warranty, fraudulent misrepresentation, fraudulent concealment, and violations of applicable Colorado law prohibiting consumer fraud and unfair and deceptive trade practices.

Overview: Bard Eclipse IVC Filter Lawsuit

Mary’s claim is filed as part of a large multidistrict litigation (MDL) centered on allegations that Bard’s IVC filters cause patients to suffer complications more exorbitantly than what they were led to expect following warnings and other IVC filter information provided by C.R. Bard.

The allegations in Mary’s case, filed through the Bard Eclipse IVC filter lawsuit did not specifically state what adverse side effects and complications Mary may have suffered as a result of the device’s implantation. However, a number of adverse side effects and complications are associated with the device.

IVC Filter Problems

Issues reported with the IVC filters include the lodging of loose fragmented pieces from the IVC filter that may become stuck in a patient’s lungs or heart, filter migration, filter fracture, device infection, and perforated organs. When a filter device fractures or comes apart, it leaves parts of the IVC filter device and fragments within the patient’s bloodstream that can then cause even more serious complications.

The device was manufactured by the company to become implanted within the inferior vena cava, the vein that returns deoxygenated blood back to the heart for replenishment. What the device does is “filter” blood clots from the blood, preventing them from traveling to the heart or lungs where they can do significant harm.

However, plaintiffs allege that the manufacturers knew that their product could lead to severe side effects and complications, and that they failed to warn consumers and the public of the potential for these occurrences. The manufacturers are being accused of continuing to sell the IVC filter despite the risks, and placing profits and revenue over consumer and patient safety.

Plaintiffs seek to hold C.R. Bard responsible for causing the severe damages, side effects, complications, and unexpected deaths that patients have suffered from.

The Bard Eclipse IVC Filter Lawsuit is Case No. 2:18-cv-02236-DGC, in the U.S. District Court for the District of Arizona. The Bard IVC Filter MDL is In re: Bard IVC Filters Products Liability Litigation, MDL No. 2:15-MD-02641-DGC, in the U.S. District Court for the District of Arizona.